Accentia Biopharmaceuticals INC
SEC CIK 1310094 · ABPI · last insider filing 2013-11-12
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Odonnell Francis E JR | Director · Executive Chairman | filed 2006 - 2013 |
| King Edmund | Director | filed 2006 - 2012 |
| Chapman Christopher C | Director | filed 2008 - 2012 |
| Schubert David M | Director | filed 2008 - 2012 |
| Poole William | Director | filed 2007 - 2012 |
| Pearce Alan M | Director · Chief Financial Officer | filed 2007 - 2011 |
| Dubinsky John P | Director | filed 2006 - 2008 |
| Arikian Steven | Director · See General Remarks | filed 2008 - 2008 |
| Stogel Steven J | Director | filed 2006 - 2007 |
| Ryll Dennis L | Director | filed 2006 - 2007 |
| Thomason Todd D | Director | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Duffey Samuel S | PRESIDENT AND GENERAL COUNSEL | filed 2007 - 2012 |
| Hasara Garrison J. | Acting Chief Financial Officer | filed 2011 - 2012 |
| Calder Douglas W | VP Strategic Plan/Cap Markets | filed 2011 - 2012 |
| Santos Carlos | Sr. VP of Prod Dev/Reg Affairs | filed 2011 - 2012 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.